Log In
Print
BCIQ
Print
Print this Print this
 

PanBlok (ASP7373, UMN-0501)

Also known as: ASP-7373

  Manage Alerts
Collapse Summary General Information
Company Protein Sciences Corp.
DescriptionPurified recombinant hemagglutinin antigen from the H5N1 avian pandemic influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against H5N1 avian influenza infection
Regulatory Designation
Partner Astellas Pharma Inc.; Ildong Pharmaceutical Co. Ltd.; Laboratorios Liomont S.A. de C.V.; UMN Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today